1. Pfizer: $9.4 billion
2. Roche: $9.2 billion
3. Merck: $8.12 billion
4. Novartis: $8.08 billion
5. Johnson & Johnson: $6.84 billion
6. GlaxoSmithKline: $6.09 billion
7. Sanofi-Aventis: $5.94 billion
8. AstraZeneca: $5.3 billion
9. Eli Lilly: $4.88 billion
10. Bristol-Myers Squibb: $3.56 billion
Tied for 10th. Takeda Pharmaceutical: $3.5 billion
Aucun commentaire:
Enregistrer un commentaire